Jonathan Rigby
Chairman chez BIOPLUS ACQUISITION CORP.
Fortune : 47 700 $ au 31/03/2024
Profil
Jonathan M.
N.
Rigby was the founder of Zogenix, Inc. (founded in 2006) where he held the title of Vice President-Business Development from 2006 to 2010.
He is currently the Group Chief Executive Officer & Director at Revolo Biotherapeutics Ltd.
(since 2020).
He is also the Chairman at the Association of Needle-Free Injection Manufacturers (since 2010), Chairman & Chief Business Officer at BioPlus Acquisition Corp.
(since 2021), Director at Oncolytics Biotech, Inc. (since 2022), Director at Thermalin, Inc., and Director at ImmunoMolecular Therapeutics, Inc. (since 2021).
Mr. Rigby's former positions include President, Chief Executive Officer & Director at SteadyMed Therapeutics, Inc. (from 2011 to 2019), President, Chief Executive Officer & Director at SteadyMed Ltd., Chairman at CollPlant Biotechnologies Ltd.
(in 2019), Independent Non-Executive Director at Xeris Pharmaceuticals, Inc. (from 2016 to 2019), Vice President-Business Development at Aradigm Corp.
(from 2002 to 2006), and Head-Business Development & Sales at Respironics Ltd.
(from 1995 to 2002).
Mr. Rigby's education includes an undergraduate degree from The University of Sheffield and an MBA from the University of Portsmouth.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC.
0,06% | 07/03/2024 | 45 000 ( 0,06% ) | 47 700 $ | 31/03/2024 |
Postes actifs de Jonathan Rigby
| Sociétés | Poste | Début |
|---|---|---|
| BIOPLUS ACQUISITION CORP. | Chairman | 01/07/2021 |
| ONCOLYTICS BIOTECH INC. | Director/Board Member | 07/09/2022 |
| Association of Needle-Free Injection Manufacturers | Chairman | 07/09/2010 |
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Chief Executive Officer | 27/03/2020 |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | Director/Board Member | 27/01/2021 |
Thermalin, Inc.
 Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Director/Board Member | - |
Anciens postes connus de Jonathan Rigby
| Sociétés | Poste | Fin |
|---|---|---|
SteadyMed Therapeutics, Inc.
 SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA. | Chief Executive Officer | 01/11/2019 |
| COLLPLANT BIOTECHNOLOGIES LTD. | Chairman | 23/08/2019 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Director/Board Member | 08/05/2019 |
| ░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jonathan Rigby
| The University of Sheffield | Undergraduate Degree |
| University of Portsmouth | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ONCOLYTICS BIOTECH INC. | Health Technology |
| COLLPLANT BIOTECHNOLOGIES LTD. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Respironics Ltd.
 Respironics Ltd. Financial ConglomeratesFinance Respironics Ltd. develops and manufactures medical and healthcare products. Its products include Porta-Neb, Freeway Freedom, Sidestream, and Ventstream. The company was founded in 1977 and is headquartered in Bognor Regis, the United Kingdom. | Finance |
| Association of Needle-Free Injection Manufacturers | |
SteadyMed Therapeutics, Inc.
SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA. | Health Services |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Health Technology |
SteadyMed Ltd.
 SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | Health Technology |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
BioPlus Acquisition Corp.
 BioPlus Acquisition Corp. Financial ConglomeratesFinance BioPlus Acquisition Corp. is an early stage blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It focuses on identifying an opportunity in the life sciences industry. The company was founded on February 11, 2021 and is headquartered in New York, NY. | Finance |
